| Description | APRT Human Pre-designed siRNA Set A contains three designed siRNAs for APRT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components APRT siRNA-1: 5 nmol (HPLC) APRT siRNA-2: 5 nmol (HPLC) APRT siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 APRT Human Pre-designed siRNA Set A contains three designed siRNAs for APRT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components APRT siRNA-1: 5 nmol (HPLC) APRT siRNA-2: 5 nmol (HPLC) APRT siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | The Leuconostoc GPDH exhibits dual coenzyme specificity, namely NAD and NADP (Olive and Levy, Biochem., 6, 730 730, 1967). When assayed under conditions that are optimal for the particular coenzyme, the ratio of observed catalytic activity is NAD/NADP = 1.8 | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA induces Th1 cytokine response as well as relatively high levels of IgG antibodies. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA produces a relapsing-remitting neurological disease with extensive plaque-like demyelination... Read More | Inquire | Inquire |